Garantir la souveraineté sanitaire de la France

This bill aims to strengthen France's ability to produce essential medicines and health products domestically. It seeks to reduce reliance on foreign supply chains and ensure access to critical healthcare resources. The proposal could affect pharmaceutical companies, healthcare providers, and patients by potentially influencing drug availability, manufacturing locations, and national health security strategies.